Sens. Grassley, Braun Submits Op-Ed on Prescription Drug Pricing Reduction Act
October 29, 2019
October 29, 2019
WASHINGTON, Oct. 29 -- Sens. Charles E. Grassley, R-Iowa, and Mike Braun, R-Indiana, issued the following op-ed on how the Prescription Drug Pricing Reduction Act can reduce drug costs, which was provided to the Washington Times:
The cost of prescription drugs is too high, plain and simple. It's a chorus we hear repeatedly from our constituents in Indiana and Iowa. If you ask any of our colleagues in the Senate and House of Representatives, you'll almost certainly hear the same thin . . .
The cost of prescription drugs is too high, plain and simple. It's a chorus we hear repeatedly from our constituents in Indiana and Iowa. If you ask any of our colleagues in the Senate and House of Representatives, you'll almost certainly hear the same thin . . .